ImmunoPrecise Antibodies (ImmunoPrecise Antibodies) Current Deferred Revenue : $1.51 Mil (As of Jan. 2024)

View and export this data going back to 2011. Start your Free Trial

What is ImmunoPrecise Antibodies Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

ImmunoPrecise Antibodies's current deferred revenue for the quarter that ended in Jan. 2024 was $1.51 Mil.

ImmunoPrecise Antibodies Current Deferred Revenue Historical Data

The historical data trend for ImmunoPrecise Antibodies's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Current Deferred Revenue Chart

ImmunoPrecise Antibodies Annual Data

Trend

Dec13

Dec14

Dec15

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Current Deferred Revenue

Get a 7-Day Free Trial

0.54

1.05

0.89

0.82

0.73

ImmunoPrecise Antibodies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Current Deferred Revenue	Get a 7-Day Free Trial															0.61	0.73	0.85	1.18	1.51

ImmunoPrecise Antibodies Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoPrecise Antibodies (ImmunoPrecise Antibodies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

TQB:Germany

Address

3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8

Website

https://www.immunoprecise.com

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.